Eco Animal Health Sustainability Profile
Eco Animal Health Ltd, headquartered in Great Britain, is a leading player in the global animal health industry, specialising in innovative solutions for livestock and aquaculture. Founded in 2004, the company has made significant strides in developing unique products that enhance animal welfare and productivity. With a strong presence in Europe, Asia, and the Americas, Eco Animal Health focuses on a range of core services, including the development of pharmaceuticals and nutritional products tailored for various species. Their flagship products, such as Aivlosin® and EcoVax®, are renowned for their efficacy and safety, setting them apart in a competitive market. Recognised for their commitment to research and development, Eco Animal Health has achieved notable milestones, positioning themselves as a trusted partner in animal health management worldwide.
DitchCarbon Score
How does Eco Animal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eco Animal Health's score of 64 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eco Animal Health's reported carbon emissions
In 2024, Eco Animal Health reported total carbon emissions of approximately 50390000 kg CO2e for Scope 1, 33157000 kg CO2e for Scope 2 (market-based), and 569110000 kg CO2e for Scope 3. This reflects a slight decrease in Scope 1 emissions from 50946000 kg CO2e in 2023 and 53287000 kg CO2e in 2022. Scope 2 emissions also saw a minor reduction from 33509000 kg CO2e in 2023 to 33157000 kg CO2e in 2024. The company has set an ambitious target to reduce its total greenhouse gas emissions by 42% by the end of 2030, using 2021 as the baseline year. This commitment encompasses all scopes of emissions (1, 2, and 3) and aligns with the Science Based Targets initiative (SBTi) validated near-term emission reduction targets. Eco Animal Health's emissions data is cascaded from its parent company, ECO Animal Health Group plc, which provides a comprehensive overview of the organisation's climate impact. The company is actively working towards achieving its reduction goals while addressing the significant challenges posed by its Scope 3 emissions, which constitute the majority of its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 9,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 11,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Eco Animal Health's Industry?
How Carbon Intensive is Eco Animal Health's Location?
Eco Animal Health's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eco Animal Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
